Concordance index: Surrogacy of progression-free survival for overall survival-Reference-Cited by-同舟云学术

Concordance index: Surrogacy of progression-free survival for overall survival

Published:2021-05 Issue: Volume:104 Page:106353
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Fan Yiwei,Yin Guosheng

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference20 articles.

1. Detecting an overall survival benefit that is derived from progression-free survival;Broglio;J. Natl. Cancer Inst.,2009

2. Effect of adjuvant paclitaxel and carboplatin on survival in women with triple-negative breast cancer: a phase 3 randomized clinical trial;Yu;JAMA Oncol.,2020

3. Detecting overall survival benefit derived from survival postprogression rather than progression-free survival;Morita;J. Natl. Cancer Inst.,2015

4. Progression-free survival (PFS) as a surrogate endpoint for overall survival (OS) in advanced/recurrent gastric cancer (AGC) treatment: Individual-patient-data (IPD) based meta-analysis of randomized trials;Oba;J. Clin. Oncol.,2020

5. Progression-free survival as a surrogate for overall survival in clinical trials of targeted therapy in advanced solid tumors;Michiels;Drugs,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Altered expression of ACOX2 in non-small cell lung cancer;BMC Pulmonary Medicine;2022-08-23

2. Intraductal papillary carcinoma of breast with invasion: A nomogram and survival from the analysis of the SEER database;Cancer Medicine;2022-07-15

3. An Adaptive Transfer-Learning-Based Deep Cox Neural Network for Hepatocellular Carcinoma Prognosis Prediction;Frontiers in Oncology;2021-09-27